Abstract
Despite extensive research, the current theories on serotonergic dysfunctions and cortisol hypersecretion do not provide sufficient explanations for the nature of depression. Rational treatments aimed at causal factors of depression are not available yet. With the currently available antidepressant drugs, which mainly target serotonin, less than two thirds of depressed patients achieve remission. There is now evidence that inflammatory and neurodegenerative (I&ND) processes play an important role in depression and that enhanced neurodegeneration in depression may–at least partly–be caused by inflammatory processes. Multiple inflammatory-cytokines, oxygen radical damage, tryptophan catabolites–and neurodegenerative biomarkers have been established in patients with depression and these findings are corroborated by animal models of depression. A number of vulnerability factors may predispose towards depression by enhancing inflammatory reactions, e.g. lower peptidase activities (dipeptidyl-peptidase IV, DPP IV), lower omega-3 polyunsaturated levels and an increased gut permeability (leaky gut). The cytokine hypothesis considers that external, e.g. psychosocial stressors, and internal stressors, e.g. organic inflammatory disorders or conditions, such as the postpartum period, may trigger depression via inflammatory processes. Most if not all antidepressants have specific anti-inflammatory effects, while restoration of decreased neurogenesis, which may be induced by inflammatory processes, may be related to the therapeutic efficacy of antidepressant treatments. Future research to disentangle the complex etiology of depression calls for a powerful paradigm shift, i.e. by means of a high throughput-high quality screening, including functional genetics and genotyping microarrays; established and novel animal and ex vivo–in vitro models for depression, such as new transgenic mouse models and endophenotype-based animal models, specific cell lines, in vivo and ex vivo electroporation, and organotypic brain slice culture models. This screening will allow to: 1) discover new I&ND biomarkers, both at the level of gene expression and the phenotype; and elucidate the underlying molecular I&ND pathways causing depression; and 2) identify new therapeutic targets in the I&ND pathways; develop new anti-I&ND drugs for these targets; select existing anti-I&ND drugs or substances that could augment the efficacy of antidepressants; and predict therapeutic response by genetic I&ND profiles.
Similar content being viewed by others
References
Amodio P, De Toni EN, Cavalletto L, Mapelli D, Bernardinello E, Del Piccolo F, Bergamelli C, Costanzo R, Bergamaschi F, Poma SZ, Chemello L, Gatta A, Perini G (2005) Mood, cognition and EEG changes during interferon (αIFN) treatment for chronic hepatitis C. J. Affect. Disord. 84(1):93–98
Angelucci F, Brene S, Mathe AA (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10(4):345–352
Anisman H, Kokkinidis L, Merali Z (2002) Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Beh. Immun. 16(5):544–556 Review
Anisman H, Merali Z, Poulter MO, Hayley S (2005) Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Design 11(8):963–972
Anisman H, Poulter MO, Gandhi R, Merali Z, Hayley S (2007) Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J. Neuroimmunol. 186(1–2):45–53
Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimaki T (2007) Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J. Neural. Transm. 114(8):1065–1068
Babcock TA, Carlin JM (2000) Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12(6):588–594
Banerjee A, Jain G, Grover S, Singh J (2007) Mania associated with interferon. J. Postgraduate Med. 53(2):150
Bazan NG, Marcheselli VL, Cole-Edwards K (2005) Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. NY Acad. Sci. 1053:137–147 Review
Beck RD Jr., Wasserfull C, Ha GK, Cushman JD, Huang Z, Atkinson MA, Petitto JM (2005) Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 1041:223–230
Beltz BS, Sandeman DC (2003) Regulation of life-long neurogenesis in the decapod crustacean brain. Arth. Struct. Dev. 32:39–60
Beltz BS, Tlusty MF, Benton JL, Sandeman DC (2007) Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett. 145(2):154–158
Benazzi F (2007a) Bipolar II Disorder : Epidemiology, Diagnosis and Management. CNS Drugs. 21(9):727–740
Benazzi F (2007b) Is there a continuity between bipolar and depressive disorders? Psychoth. Psychosom. 76(2):70–76
Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can. J. Psychiatry 52(1):46–54
Bjornebekk A, Mathe AA, Brene S (2005) The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int. J. Neuropsychopharmacol. 8(3):357–368
Bjørnebekk A, Mathé AA, Gruber SH, Brené S (2007) Social isolation increases number of newly proliferated cells in hippocampus in female flinders sensitive line rats. Hippocampus. 17(12):1193–1120
Bjørnebekk A, Mathé AA, Gruber SH, Brené S (2008) Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry. Int. J. Neuropsychopharmacol. 23:1–13
Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M (2001) Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res. 105(1–2):45–55
Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M (2002a) Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J. Affect. Disord. 72(3):237–241
Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002b) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 22(1):86–90
Bremner JD, Narayan M (1998) The effects of stress on memory and the hippocampus throughout the life cycle: implications for childhood development and aging. Developm. Psychopathol. 10(4):871–885
Brown ES, Rush AJ, McEwen BS (1999) Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacol. 21(4):474–484
Brown ES, J Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 55(5):538–545
Bukalo O, Fentrop N, Lee AY, Salmen B, Law JW, Wotjak CT, Schweizer M, Dityatev A, Schachner M (2004) Conditional ablation of the neural cell adhesion molecule reduces precision of spatial learning, long-term potentiation, and depression in the CA1 subfield of mouse hippocampus. J. Neurosci. 24:1565–1577
Campbell S, MacQueen G (2006) An update on regional brain volume differences associated with mood disorders. Curr. Opin. Psychiatry 19(1):25–33
Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH (2003) Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol. Psychiatry 54(9):906–914
Carter CJ (2007) Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem. Int. 50(3):461–490
Castanon N, Bluthé RM, Dantzer R (2001) Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacol. 154(1):50–60
Chavez AM, Menconi MJ, Hodin RA, Fink MP (1999) Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit. Care Med. 27(10):2246–2251
Checa N, Canals JM, Alberch J (2000) Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections. Exp. Neurology 165(1):118–124
Chung KK, Dawson TM, Dawson VL (2005) Nitric oxide, S-nitrosylation and neurodegeneration. Cell Mol. Biol. (Noisy-le-grand) 51(3):247–254 Review
Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G (2005) Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterol. 128(5):1258–1267
Contestabile A (2001) Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr. Topics Med. Chemistry 1(6):553–568 Review
Coti Bertrand P, O'Kusky JR, Innis SM (2006) Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J. Nutr. 136(6):1570–1575
Cowen PJ (2002) Cortisol, serotonin and depression: all stressed out? Brit. J. Psychiatry 180:99–100
de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nature Immunol 6(8):844–851
Dinan T (2001) Novel approaches to the treatment of depression by modulating the hypothalamic—pituitary—adrenal axis. Hum. Psychopharmacol. 16(1):89–93
Duman RS (2002) Pathophysiology of depression: the concept of synaptic plasticity. Eur. Psychiatry 17(Suppl 3):306–310
Duman RS (2004) Depression: a case of neuronal life and death? Biol. Psychiatry 56(3):140–145
Ehninger D, Kempermann G (2006) Paradoxical effects of learning the Morris water maze on adult hippocampal neurogenesis in mice may be explained by a combination of stress and physical activity. Genes Brain Beh. 5(1):29–39
Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc. Nat. Acad. Sci. USA. 100(23):13632–13637
el-Defrawy SR, Boegman RJ, Jhamandas K, Beninger RJ (1986) The neurotoxic actions of quinolinic acid in the central nervous system. Can. J. Physiol. Pharmacol. 64(3):369–375
Fitzgerald P, O'Brien SM, Scully P, Rijkers K, Scott LV, Dinan TG (2006) Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol. Med. 36(1):37–43
Forlenza MJ, Miller GE (2006) Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosomatic Med. 68(1):1–7
Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur. Neuropsychopharmacol. 5(14 Suppl):S481–490
Garthwaite G, Garthwaite J (1987) Quinolinate mimics neurotoxic actions of N-methyl-D-aspartate in rat cerebellar slices. Neurosci. Lett. 79(1–2):35–39
Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E (1997) Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation.J. Neurosci. 17(7):2492–2498
Guillemin GJ, Smith DG, Kerr SJ, Smythe GA, Kapoor V, Armati PJ, Brew BJ (2000) Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Report 5(2–3):108–111
Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13(7):717–728
Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol. Psychiatry 12:1079–1088
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97(6):1634–1658 Review
Hand R, Bortone D, Mattar P, Nguyen L, Heng JI, Guerrier S, Boutt E, Peters E, Barnes AP, Parras C, Schuurmans C, Guillemot F, Polleux F (2005) Phosphorylation of neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex. Neuron 48(1):45–62
Henn FA, Vollmayr B (2004) Neurogenesis and depression: etiology or epiphenomenon? Biol. Psychiatry 56(3):146–150
Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A et al (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(Pt 5):1249–1273
Hibbeln JR (1998) Fish consumption and major depression. Lancet 351(9110):1213
Hibbeln JR (2002) Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69(1–3):15–29
Horrobin DF (2001) Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase. Hum. Psychopharmacol. 16(1):45–52
Huang SY, Yang HT, Chiu CC, Pariante CM, Su KP (2006) Omega-3 fatty acids on the forced-swimming test. J. Psychiatr. Res. 42(1):58–63
Ishikawa I, Kitamura H, Kimura K, Saito M (2001) Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats. Jap. J. Veterinary Res. 49(1):19–25
Kawakita E, Hashimoto M, Shido O (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neurosci. 139(3):991–997
Kempermann G, Neumann H (2003) Microglia: the enemy within? Science 302:1689–1690
Kempermann G, Kuhn HG, Gage FH (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386(6624):493–495
Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int. J. Neuropsychopharmacol. 5(4):401–412 Review
Kent S, Bluthé RM, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13(1):24–28
Kerr SJ, Armati PJ, Guillemin GJ, Brew BJ (1998) Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 12(4):355–363
Khaspekov L, Kida E, Victorov I, Mossakowski MJ (1989) Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus. J. Neurosci. Res. 22(2):150–157
Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, Steinbusch HW (2004) T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatr. Res. 129(3):267–272
Kim YK, Jung HG, Myint AM, Kim H, Park SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J. Affect. Disord. 104(1–3):91–95
Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS. Medicine 5(2):e45
Koo JW Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Nat. Acad. Sci. USA 105:751–756
Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M (1996) Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol. 48:503–506
Kubera M, Van Bockstaele D, Maes M (1999) Leukocyte subsets in treatment-resistant major depression. Pol. J. Pharmacol. 51(6):547–549
Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001a) Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J. Clin. Psychopharmacol. 21(2):199–206
Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J (2001b) Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J. Affect. Disord. 63(1–3):171–178
Kwidzinski E, Bunse J, Aktas O, Richter D, Mutlu L, Zipp F, Nitsch R, Bechmann I (2005) Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19(10):1347–1349
Lacosta S, Merali Z, Anisman H (1999) Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818(2):291–303
Lapin IP (2003) Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety. Adv. Exp. Med. Biol. 527:121–125
Lestage J, Verrier D, Palin K, Dantzer R (2002) The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16(5):596–601
Levivier M, Przedborski S (1998) Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment. Neurol. Res. 20(1):46–56
Lin A, Song C, Kenis G, Bosmans E, De Jongh R, Scharpe S, Maes M (2000) The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J. Affect. Disord. 58(1):69–74
Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatr. 68(7):1056–1061
Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, Souza DO, Portela LV, Gentil V (2007a) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Psychiatry 61(2):142–144
Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, Kapczinski F, Portela LV, Souza DO, Salvador M, Gentil V (2007b) Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci. Lett. 421(1):33–36
Maes M (1993) A review on the acute phase response in major depression. Rev. Neurosci. 4(4):407–416 Review
Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Progr. Neuropsychopharmacol. Biol. Psychiatry 19(1):11–38 Review
Maes M (1999) Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 461:25–46 Review
Maes M, Meltzer HY (1995) The Serotonin Hypothesis of major depression. Psychopharmacology, The Fourth Generation of Progress. In: Bloom F, Kupfer D (Ed) Raven Press, pp 933–944
Maes M, Smith RS (1998) Fatty acids, cytokines, and major depression. Biol. Psychiatr. 43(5):313–314
Maes M, De Ruyter M, Claes R, Bosma G, Suy E (1987) The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients. J. Affect. Disord. 13(1):23–30
Maes M, De Ruyter M, Claes R, Suy E (1988) Sex-related differences in the relationships between self-rated depression and biological markers. J. Affect. Disord. 15(2):119–125
Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiol. 24(3):115–120
Maes M, De Meester I, Vanhoof G, Scharpe S, Bosmans E, Vandervorst C, Verkerk R, Minner B, Suy E, Raus J (1991) Decreased serum dipeptidyl peptidase IV activity in major depression. Biol. Psychiatry 30(6):577–586
Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993a) Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am. J. Psychiatry 150(8):1189–1193
Maes M, Meltzer HY, Scharpe S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P (1993b) Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatr. Res. 49(2):151–165
Maes M, Meltzer HY, Scharpé S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C, Calabrese J, Raus J, Cosyns P (1993c) Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatr. Res. 47(3):229–241
Maes M, Scharpe S, Meltzer HY, Cosyns P (1993d) Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol. Psychiatry 34(10):690–701
Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993e) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-drenal axis in severe depression. Psychiatr. Res. 49(1):11–27
Maes M, Scharpe S, Meltzer H, Okayli G, D'Hondt P, Cosyns P (1994) Increased neopterin and interferon gamma secretion and lower L-tryptophan levels in major depression: further evidence for immune activation in severe depression. Psychiatr. Res. 54:143–160
Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995a) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatry Res. 29(2):141–152
Maes M, Smith R, Scharpe S (1995b) The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinol. 20(2):111–116
Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996a) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 38(1):35–46
Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A, Cosyns P, Scharpe S, Desnyder R (1996b) Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacol. 15(3):243–251
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997a) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9(11):853–858
Maes M, Calabrese J, Jayathilake K, Meltzer HY (1997b) Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission. Psychiatr. Res. 71(2):67–76
Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S (1997c) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatr. Res. 66(1):1–11
Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R (1997d) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol. Psychiatry 42(5):349–358
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS (1998a) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10(4):313–318
Maes M, Song C, Lin A, DeJong R, Van Gastel A, Kenis G, Bosmans E, DeMeester I, Neels H, Janca A, Scharpe S, Smith RS (1998b) Immune and clinical correlates of psychological stress-induced production of interferon-( and IL-10 in humans. In: Plotnikoff NP, Faith RE, Murgo AJ, Good RA (eds) Cytokines, Stress and Immunity, pp 39–50
Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999a) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatr. Res. 85(3):275–291
Maes M, Libbrecht I, van Hunsel F, Campens D, Meltzer HY (1999b) Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. J. Clin. Psychopharmacol. 19(2):177–182
Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S (1999c) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacol. 20(4):370–379
Maes M, Song C, Lin AH, Pioli R, Kenis G, Kubera M, Bosmans E (1999d) In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacol. (Berl) 143(4):401–407
Maes M, Van Bockstaele DR, Gastel A, Song C, Schotte C, Neels H, DeMeester I, Scharpe S, Janca A (1999e) The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiol. 39(1):1–9
Maes M, Christophe A, Bosmans E, Lin A, Neels H (2000) In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol. Psychiatr. 47(10):910–920
Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, Dantzer R, Neveu PJ (2001a) Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacol. 24(2):130–140
Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E (2001b) The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J. Affect. Disord. 63(1–3):85–92
Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S (2001c) Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol. Med. 31(5):847–858
Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S (2002) Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci. 71(16):1837–1848
Maes M, Mihaylova I, Bosmans E (2007a) Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol. Lett. 28(4):456–462
Maes M, Mihaylova I, DeRuyter MD, Kubera M, Bosmans E (2007b) The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression–and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol. Lett. 28(6):826–831
Maes M, Mihaylova I, Kubera M, Bosmans E (2007c) Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol. Lett. 28(4):463–469
Maes M, Mihaylova I, Leunis JC (2007d) Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol. Lett. 28(6):861–867
Maes M, Mihaylova I, Ategis J-C (2008a) Evidence for an IgM-mediated immune response directed against nitro-bovine serum albumin (BSA) in chronic fatigue syndrome (CFS) and major depression (MDD): evidence that the immune response to nitrosative stress-induced damage of BSA is more pronounced in CFS than in MDD. Neuro Endocrinol. Lett. 2008, In press
Maes M, Kubera M, Leunis JC (2008b) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Letters. 29(1):117–124
Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20(24):9104–9110
Mamalakis G, Kalogeropoulos N, Andrikopoulos N, Hatzis C, Kromhout D, Moschandreas J, Kafatos A (2006) Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur. J. Clin. Nutr. 60(7):882–888
Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L (2006) Mitochondrial dysfunction, oxidative stress and neurodegeneration. J. Alzheimer’s Dis. 10(1):59–73 Review
Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, Wisniewski SR, Balasubramani GK, Trivedi MH, Rush AJ (2005) Gender differences in depression: findings from the STAR*D study. J. Affect. Disord. 87(2–3):141–150
Miller CL, Llenos IC, Dulay JR, Weis S (2006) Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 1073–1074:25–37
Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP (2001) Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch. Neurol. 58(7):1081–1086
Moncada S, Bolanos JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97(6):1676–1689 Review
Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765
Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ (2007) Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatr. 61(2):187–197
Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatr. 11(7):680–684
Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. New Engl. J. Med. 344(13):961–966
Myint AM, Kim YK, Verkerk R, Park SH, Scharpe S, Steinbusch HW, Leonard BE (2007) Tryptophan breakdown pathway in bipolar mania. J. Affect. Disord. 102(1–3):65–72
Ngai LY, Herbert J (2005) Glucocorticoid enhances the neurotoxic actions of quinolinic acid in the striatum in a cell-specific manner. J. Neuroendocrinol. 17(7):424–434
Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF (1998) Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 18:2239–2246
Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, Montero M, Meyer M, Gramsbergen JB, Zimmer J (2005) Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets. CNS Neurol. Disord. 4(4):435–452 Review
Noraberg J, Jensen CV, Bonde C, Montero M, Nielsen JV, Jensen NA, Zimmer J (2007) Developmental expression of fluorescent proteins in organotypic hippocampal slice cultures from transgenic mice with example of excitotoxic neurodegeneration. ATLA. 35(1):61–70 Review
O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 41(3–4):326–331
O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2008) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry. [Epub ahead of print]
Overstreet DH, Friedman E, Mathé AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobeh. Rev. 29(4–5):739–759
Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatr. 49(5):391–404
Patel HC, Ross FM, Heenan LE, Davies RE, Rothwell NJ, Allan SM (2006) Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. J. Neurosci. Res. 83(3):385–391
Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatr. 43(5):315–319
Pemberton LA, Kerr SJ, Smythe G, Brew BJ (1997) Quinolinic acid production by macrophages stimulated with IFNγ, TNF-alpha, and IFNα. J. Interf. Cytokine Res. 17(10):589–595
Periyasamy S, Sanchez ER (2002) Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression. Int. J. Biochem. Cell Biol. 34(12):1571–1585
Pettit JW, Lewinsohn PM, Joiner TE Jr (2006) Propagation of major depressive disorder: relationship between first episode symptoms and recurrence. Psychiatr. Res. 141(3):271–278
Pláteník J, Stopka P, Vejrazka M, Stípek S (2001) Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction. Free Radical Res. 34(5):445–459
Polleux F, Ghosh A (2002) The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development. Science STKE 136(19):1–11
Pong K (2003) Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Exp. Opin. Biol. Therap. 3(1):127–139 Review
Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry 149(8):999–1010
Post RM (2007) Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev 31(6):858–873
Potashkin JA, Meredith GE (2006) The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxidant Redox Sign. 8(1–2):144–151 Review
Qian L, Hong JS, Flood PM (2006) Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. J. Neural Transm. Suppl. 70:367–371
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5):453–462
Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol. Psychiatr. 13(6):585–596
Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 16(10):1139–1143
Sakic B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA (1997) Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 44(2):155–165
Sakic B, Gauldie J, Denburg JA, Szechtman H (2001) Behavioral effects of infection with IL-6 adenovector. Brain Beh Immun. 15(1):25–42
Sandi C (2004) Stress, cognitive impairment and cell adhesion molecules. Nature Reviews Neuroscience 5:917–930
Sandi C, Bisaz R (2007) A model for the involvement of neural cell adhesion molecules in stress-related mood disorders. Neuroendocrinol. 85(3):158–176
Sapolsky RM (2004) Is impaired neurogenesis relevant to the affective symptoms of depression? Biol. Psychiatry 56(3):137–139
Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 22(2):67–73
Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol. Biol. Psychiatr. 29(2):201–217
Schmidt HD, Duman RS (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Beh. Pharmacol. 18(5–6):391–418
Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A (2005) Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J. Neuroimmunol. 160(1–2):204–209
Schwarcz R, Köhler C (1983) Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38(1):85–90
Shapira-Lichter I, Beilin B, Ofek K, Bessler H, Gruberger M, Shavit Y, Seror D, Grinevich G, Posner E, Reichenberg A, Soreq H, Yirmiya R (2008) Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory. Brain Beh. Immun. 22:388–398
Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15:1768–1777
Sobocki P, Jonsson B, Angst J, Rehnberg C (2006) Cost of depression in Europe. J. Ment. Health Policy Econ. 9(2):87–98
Sobczak S, Honig A, Christophe A, Maes M, Helsdingen RW, De Vriese SA, Riedel WJ (2004) Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients. Psychol. Med 34(1):103–112
Song C, Leonard BE (1995) Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation. 2(5):263–273
Song C, Leonard BE, Horrobin DF (2004) Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress 7(1):43–54
Song C, Li X, Kang Z, Kadotomi Y (2007) Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion. Neuropsychopharmacol. 32(3):736–744
Steptoe A, Hamer M, Chida Y (2007) The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Beh. Immun. 21:901–912
Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G (2004) Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatr. 56(9):640–650
Stone TW, Behan WM (2007) Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J. Neurosci. Res. 85(5):1077–1085
Stork O, Welzl H, Wotjak CT, Hoyer D, Delling M, Cremer H, Schachner M (1999) Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice. J. Neurobiol. 40:343–355
Turner CA, Akil H, Watson SJ, Evans SJ (2006) The fibroblast growth factor system and mood disorders. Biol. Psychiatr. 59(12):1128–1135
Ueda S, Sakakibara S, Yoshimoto K (2005) Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning. Neurosci. 135:395–402
Vaidya VA, Duman RS (2001) Depression-emerging insights from neurobiology. Brit. Med. Bull. 57:61–79
van Praag H, Kempermann G, Gage FH (1999) Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nature Neurosci. 2(3):266–270
Viviani B, Gardoni F, Bartesaghi S, Corsini E, Facchi A, Galli CL, Di Luca M, Marinovich M (2006) Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J. Biol. Chem. 281(40):30212–3022
Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M (2002) Serological observations in patients suffering from acute manic episodes. Human Psychopharmacol. 17(4):175–179
Walz JC, Frey BN, Andreazza AC, Cereser KM, Cacilhas AA, Valvassori SS, Quevedo J, Kapczinski F (2007) Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J. Psychiatr. Res. 42(5):416–421
Wang JY, Wen LL, Huang YN, Chen YT, Ku MC (2006) Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr. Pharmac. Design 12(27):3521–3533 Review
Wichers MC, Maes M (2004) The role of indoleamine 2, 3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J. Psychiatr. Neurosci. 29(1):11–17
Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M (2005) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatr. 10(6):538–544
Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M (2007) Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J. Psychosom. Res. 62(2):207–214
Wu A, Ying Z, Gomez-Pinilla F (2004) Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma. 21:1457–1467
Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacol. 34(1):27–37
Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 1162:9–18
Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP (2003) IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointestinal Liver Physiol. 285(3):G621–629
Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res. 711(1–2):163–74
Yirmiya R (1997) Behavioral and psychological effects of immune activation: implications for ‘depression due to a general medical condition’. Curr. Opin. Psychiatr. 10:470–476
Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R, Barak O, Reichenberg A, Cohen E, Shavit Y, Ovadia H (1999) Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv. Exp. Med. Biol. 461:283–316
Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J (2001) Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacol. 24(5):531–544
Zhu SW, Pham TM, Aberg E, Brene S, Winblad B, Mohammed AH, Baumans V (2006) Neurotrophin levels and behaviour in BALB/c mice: impact of intermittent exposure to individual housing and wheel running. Beh. Brain Res. 167(1):1–8
Zou JY, Crews FT (2005) TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 1034(1–2):11–24
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maes, M., Yirmyia, R., Noraberg, J. et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24, 27–53 (2009). https://doi.org/10.1007/s11011-008-9118-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-008-9118-1